Target recalls Guglielmi coils:
This article was originally published in Clinica
Target Therapeutics has recalled some of its Guglielmi detachable intracranial coils because of visualisation problems. Two batches of fluoroscopic marker coils were mistakenly made from stainless steel instead of radiopaque platinum. In addition to recalling and replacing affected products, the company is asking physicians to examine all devices fluoroscopically before use. The Guglielmi coil, which is used to treat intracranial aneurysms in high-risk stroke patients, was cleared by the US FDA in September 1995 (see Clinica No 672, p 23).
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.